Bank of New York Mellon
VTAE

Bank of New York Mellon’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Bank of New York Mellon’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-87,347
Closed -$1.83M – 4384
2016
Q3 		$1.83M Sell
87,347
-372
-0.4% -$4.28K ﹤0.01% 2814
2016
Q2 		$947K Buy
87,719
+38,915
+80% +$333K ﹤0.01% 3171
2016
Q1 		$323K Buy
48,804
+6,804
+16% +$61.9K ﹤0.01% 3618
2015
Q4 		$760K Buy
42,000
+1,847
+5% +$25.4K ﹤0.01% 3328
2015
Q3 		$442K Sell
40,153
-10,631
-21% -$113K ﹤0.01% 3631
2015
Q2 		$731K Buy
50,784
+18,228
+56% +$248K ﹤0.01% 3503
2015
Q1 		$381K Buy
32,556
+13,450
+70% +$181K ﹤0.01% 3710
2014
Q4 		$318K Buy
+19,106
New +$279K ﹤0.01% 3765

Bank of New York Mellon's VTAE Position: Q4 2016 in Review

Bank of New York Mellon sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 87,347 shares — an estimated $1.83M sold.

Bank of New York Mellon first reported a position in VTAE in Q4 2014 and held it in 8 quarters. The position peaked at $1.83M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

  • Bank of New York Mellon reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
  • Bank of New York Mellon sold 87,347 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $1.83M.
  • Bank of New York Mellon first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q4 2014 and held it in 8 quarters.
  • Bank of New York Mellon's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $1.83M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Bank of New York Mellon's 13F filing for Q4 2016, filed 13 Feb 2017.